Non-Hodgkin Lymphoma | Non-Hodgkin's Lymphoma CME Learning Center

Non-Hodgkin's Lymphoma
CME Learning Center

CME Activities

Cancer Survivorship: A Primer for Primary Care CME/CE The number of cancer survivors grows each day. What are the essential components of survivorship care?
Medscape Education Family Medicine, May 2012
A 32-Year-Old Man With Hematemesis CME/CE A 32-year-old man presents to the ED with hematemesis. He has vomited bright red blood 3 times during the past 4 hours. Abdominal ultrasonography shows enlarged kidneys. What is the diagnosis?
Medscape CME Case Presentations, May 2012
Tumor Lysis Syndrome: Understanding, Preventing, and Managing an Oncologic Emergency CME/CE The 2 cases presented here help clarify several important aspects of preventing and managing tumor lysis syndrome.
Medscape Education Oncology, April 2012
B-Cell Malignancies: Updates on Current and Emerging Treatment Strategies -- Issue 8 CME Experts discuss recent advances in MM, CLL, and NHL.
Medscape Education Oncology, April 2012
Diagnosis and Management of Rare Lymphoma Subtypes: Burkitt Lymphoma CME Dr Armitage discusses the history and management of Burkitt lymphoma, one of the rarest and fastest-growing human tumors.
April 2012
Updates on Hematologic Malignancies From the 2011 ASH Meeting Faculty reviews and discusses the exciting data on AML/MDS, CML, lymphoma, and myeloma presented at the 53rd annual ASH meeting.
Medscape Education Oncology, March 2012
B-Cell Malignancies: Updates on Current and Emerging Treatment Strategies -- Issue 7 CME Experts discuss the data presented at ASH 2011 in MM, CLL, and NHL.
Medscape Education Oncology, February 2012
Focus on Lymphoma: An Update from the 2011 ASH Meeting CME Experts provide their perspectives on the most relevant abstracts related to clinical practice in lymphoma presented at the 2011 ASH meeting
Medscape Education Oncology, February 2012
Strategy for Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematologic Malignancies CME A prospective study suggests that strategies to diagnose invasive pulmonary aspergillosis should be based on the underlying condition and on the leukocyte count of patients with hematologic cancers.
Blood, February 2012
Management of the Patient With Relapsed or Refractory Follicular Lymphoma CME Dr. Bruce Cheson discuses current and emerging therapies for relapsed and refractory follicular lymphoma.
Medscape Education Oncology, January 2012
FDA Safety Changes: Boxed Warning Added to Hodgkin's Lymphoma Drug CME/CE Two new cases of progressive multifocal leukoencephalopathy, a serious brain infection that can be fatal, have been reported with use of brentuximab. A boxed warning has been added to the drug label.
Medscape Education Clinical Briefs, January 2012
Community Practice Pearl (associated with the Consensus Panel From the 2011 Pan Pacific Lymphoma Conference) Dr. Tatyana Feldman reviews some of the data presented at the 2011 Pan Pacific Lymphoma Conference and discusses salient practice points that may affect community-based clinicians.
Medscape Education Oncology, December 2011
Planning Ahead for Hematopoietic Stem Cell Transplantation in Non-Hodgkin Lymphoma CME Listen to the Satellite Symposium, where faculty discuss when to incorporate transplantation into the treatment paradigm for lymphoma.
Medscape Education Oncology, December 2011
Advances in the Therapy of Waldenström Macroglobulinemia CME Dr. Steven Treon reviews and discusses current and emerging treatment approaches for patients with Waldenström macroglobulinemia.
Medscape Education Oncology, December 2011
Diagnosis and Management of Rare Lymphoma Subtypes: CNS Lymphoma CME Dr. Batchelor discusses diagnosis of primary and secondary CNS lymphoma and its relatively few treatment options.
Medscape Education Oncology, December 2011
Consensus Panel From the 2011 Pan Pacific Lymphoma Conference CME/CE Drs. Armitage, O'Brien, Vose, and Younes discuss key highlights from the 2011 Pan Pacific Lymphoma Conference.
Medscape Education Oncology, October 2011
Follicular Lymphoma: Improving Outcomes and Evaluating Novel Treatment Approaches CME Can follicular lymphoma be "cured?" Dr. James Armitage discusses treatment options, ranging from observation to stem cell transplant.
Medscape Education Oncology, August 2011
T-Cell Lymphomas: Charting the Course of Treatment From Diagnosis to Relapsed/Refractory Cases CME Dr. Francine Foss reviews diagnostic criteria and current and emerging treatment strategies for peripheral and cutaneous T-cell lymphomas.
Medscape Education Oncology, August 2011
Follicular Lymphoma: Evaluating First-Line Treatment Options CME Listen to faculty discuss selection of first-line treatment options for follicular lymphoma based on histology and risk assessment.
Medscape Education Oncology, August 2011
Improving Outcomes and Evaluating Novel Treatment Approaches for Patients With DLBCL or MCL CME Dr. Andrew Zelenetz reviews and discusses current and emerging treatment approaches for patients with DLBCL and MCL.
Medscape Education Oncology, August 2011

FDA Safety Changes: Boxed Warning Added to Hodgkin's Lymphoma Drug CME/CE
January 2012
Overall Cancer Risk Not Increased in IBD Patients Treated With Azathioprine
February 2010
FDA Approvals: Tamiflu, Stelara, Folotyn
October 2009
FDA Approvals: Bepreve, Metozolv ODT, Zevalin
September 2009
FDA Safety Changes: Remicade and Doribax
June 2009

About Non-Hodgkin's Lymphoma

Non-Hodgkin's lymphoma is the fifth most common cancer in the United States, accounting for about 4% of all malignancies in both men and women. The disease comprises a variety of cancers of the lymphatic system exclusive of Hodgkin's lymphoma. B-cell lymphomas represent most cases of non-Hodgkin's lymphoma, and T-cell lymphomas account for the rest. Due to the myriad types of non-Hodgkin's lymphoma, classification often proves difficult for healthcare professionals. Exams and tests can help to identify the presence or absence of the disease and aid in classifying the lymphoma. Adults make up the majority of cases of non-Hodgkin's lymphoma. The incidence has increased by nearly 2-fold over the past few decades, with AIDS-related lymphoma accounting for some of this growth. Non-Hodgkin's lymphoma is seen more commonly in certain populations, such as elderly individuals, men, and whites. Children often present with different types of the disease. Recent advances in treatment, including chemotherapy, radiotherapy, and immunotherapy, have shown promise in combating this disease.

Non-Hodgkin's LymphomaCME Learning Center

CME Activities

Latest Clinical Briefs in Non-Hodgkin's Lymphoma

About Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma
CME Learning Center